MedTrace Logo

STILDEP: Zolpidem in Depressive and Dysthimic Patients

NCT00292734 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2007-12-06

No results posted yet for this study

Summary

Primary objective: To show that the combination of Zolpidem + antidepressant therapy is more effective in the treatment of the secondary insomnia of depressive and dysthimic patients than antidepressant therapy alone in the acute phase of the disease.

Conditions

  • Sleep Initiation and Maintenance Disorders
  • Depression

Interventions

DRUG

Zolpidem

Sponsors & Collaborators

Principal Investigators

  • László Erős, MD · sanofi-aventis Hungary

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Completion
2006-06-30

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00292734 on ClinicalTrials.gov